Srinivas Mummidi
Overview
Explore the profile of Srinivas Mummidi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rout M, Ramu D, Mariana M, Koshy T, Venkatesan V, Lopez-Alvarenga J, et al.
Commun Med (Lond)
. 2025 Feb;
5(1):47.
PMID: 39987249
Background: Type 2 diabetes (T2D) etiology is highly complex due to its multiple roots of origin. Polygenic risk scores (PRS) based on genome-wide association studies (GWAS) can partially explain T2D...
2.
Vanamala J, Sivaramakrishnan V, Mummidi S
Front Endocrinol (Lausanne)
. 2025 Jan;
15():1537554.
PMID: 39866737
No abstract available.
3.
Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells
Morales D, Ryu J, Wei C, Hadley J, Smith M, Bai J, et al.
Diabetologia
. 2024 Nov;
68(3):615-628.
PMID: 39589509
Aims/hypothesis: Upregulation of serum leucine-rich α-2-glycoprotein 1 (LRG1) has been implicated in diet-induced obesity and metabolic disorders. However, its specific hormonal actions remain unclear. This study aimed to determine whether...
4.
Russell J, Mummidi S, Demarco V, Grisanti L, Bailey C, Bender S, et al.
Physiol Genomics
. 2024 Feb;
56(4):360-366.
PMID: 38314697
Adverse cardiac remodeling contributes to heart failure development and progression, partly due to inappropriate sympathetic nervous system activation. Although β-adrenergic receptor (β-AR) blockade is a common heart failure therapy, not...
5.
Akhtar F, Ruiz J, Liu Y, Resendez R, Feliers D, Morales L, et al.
bioRxiv
. 2023 Nov;
PMID: 37961304
CC-chemokine ligand 2 (CCL2) is involved in the pathogenesis of several diseases associated with monocyte/macrophage recruitment, such as HIV-associated neurocognitive disorder (HAND), tuberculosis, and atherosclerosis. The rs1024611 (alleles:A>G; G is...
6.
Chandrasekar B, Mummidi S, Demarco V, Higashi Y
Mediators Inflamm
. 2023 Oct;
2023:6112301.
PMID: 37830075
Persistent oxidative stress and inflammation contribute causally to smooth muscle cell (SMC) proliferation and migration, the characteristic features of vascular proliferative diseases. Oxidatively modified low-density lipoproteins (OxLDL) elevate oxidative stress...
7.
Garcia-Oropesa E, Perales-Torres A, Martinez-Lopez Y, Munguia-Cisneros C, Nava-Gonzalez E, Perez-Navarro M, et al.
Arch Med Res
. 2023 Sep;
54(7):102873.
PMID: 37660428
Aim: Evaluate insulin resistance (IR) as a mediator of the effect of body fat distribution on liver fat infiltration and stiffness (LSt) in young adults using structural equation modeling (SEM)....
8.
Anji A, Anderson B, Akhtar F, Meekins D, Ito T, Mummidi S, et al.
Stem Cell Rev Rep
. 2023 Feb;
19(5):1152-1176.
PMID: 36811747
Exosomes play a role in tissue/organ development and differentiation. Retinoic acid induces differentiation of P19 cells (UD-P19) to P19 neurons (P19N) that behave like cortical neurons and express characteristic neuronal...
9.
Venkatesan V, Lopez-Alvarenga J, Arya R, Ramu D, Koshy T, Ravichandran U, et al.
Front Endocrinol (Lausanne)
. 2022 May;
13:847692.
PMID: 35498404
To assess the burden of type 2 diabetes (T2D) and its genetic profile in endogamous populations of India given the paucity of data, we aimed to determine the prevalence of...
10.
Garibay-Nieto N, Hernandez-Moran B, Villanueva-Ortega E, Garces-Hernandez M, Pedraza-Escudero K, Arroyo-Valerio A, et al.
Endocr Pract
. 2021 Dec;
28(3):315-320.
PMID: 34890785
Objective: To describe a third-degree polynomial function (hysteresis) of the effect size of age, obesity, and insulin sensitivity over the carotid intima-media thickness (c-IMT), in the pediatric and adult groups....